Bangladeshi researchers develop advanced drug for Hepatitis B


PV Desk : Patients infected with Hepatitis B Virus (HBV) may get much better and more effective treatment than even before as an advanced prescription medicine, developed by two Bangladeshi researchers, is set to hit local drugstores early next year after getting approval from the drug administration.
The two Bangladeshi researchers, also doctors, have developed the breakthrough medicine for treating HBV while a leading pharmaceutical company of the county will manufacture and release the drug in the local market, making it cheaper and available at major drugstores across the country.
“The therapeutic medicine named NASVAC may not be a magic drug, but it has shown a positive response rate of about 50.0 percent in case of patients infected with Hepatitis B and 100.0 percent in curing liver inflammation”, Dr Mamun Al Mahtab, the principal investigator for clinical trials of this drug, told BSS recently.
Dr. Mahtab, an Associate Professor of Department of Hepatology at Bangabandhu Sheikh Mujib Medical University, carried out the required trials while Dr Sheikh Mohammad Fazle Akbar conducted the fundamental researches for developing the medicine. BSS